- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03409900
Lumbar Plexus Block Versus Quadratus Lumborum Block for Primary Anterior Total Hip Arthroplasty
May 8, 2020 updated by: Wake Forest University Health Sciences
Lumbar Plexus Block Versus Quadratus Lumborum Block for Primary Anterior Total Hip Arthroplasty: A Non-inferiority Trial
Total hip arthroplasty (THA) is one of the most successful orthopedic procedures to effectively relieve pain and restore function in patients with end stage osteoarthritis.
In an attempt to accelerate recovery many orthopedic surgeons have opted to utilize a direct anterior approach (DAA) as opposed to the more traditional posterolateral approach (PLA).
The literature supports that DAA is superior to PLA with regard to lower blood loss, less pain, shorter hospital stay, and faster rehabilitation.
Traditionally the study team has performed Lumbar Plexus blocks (LPB) to provide post-operative analgesia for total hip arthroplasty.
The quadratus lumborum block (QLB) is a newer regional analgesic technique that may be as effective as LPB at providing pain control following DAA hip arthroplasty.
This study is designed to compare the efficacy, with regards to post-operative pain management, between LPB and QLB following a DAA total hip arthroplasty.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In an attempt to accelerate recovery many orthopedic surgeons have opted to utilize a direct anterior approach (DAA) as opposed to the more traditional posterolateral approach (PLA) in regards to total hip arthroplasty (THA).
The DAA technique involves dissection of muscular planes for insertion of components resulting in less tissue damage as compared to PLA.
Traditionally the study team has performed Lumbar Plexus blocks (LPB) to provide post-operative analgesia for total hip arthroplasty.
This technique works well for the traditionally performed PLA in that the hip joint and incision site are within the analgesic distribution of the LPB.
Conversely, the DAA utilizes an anterior incision that overlies the L1 and L2 dermatomes as opposed to the lower lumbar dermatomes of the PLA incision.
When performing LPB it has been the study team's clinical experience that it is rare to achieve analgesia in the proximal distribution of the lumbar plexus resulting in apparent sparing of the L1 and L2 nerve root distributions.
The quadratus lumborum block (QLB) is a newer regional analgesic technique that may be as effective as LPB at providing pain control following DAA hip arthroplasty.
The QLB is thought to provide analgesia by blocking both the lateral and anterior cutaneous branches of T7 through L4.
This degree of dermatomal coverage suggests that QLB could be an efficacious alternative to LPB for DAA hip arthroplasty.
It is hypothesized that the QLB will provide equivalent analgesia when compared to the LPB as determined by a comparison of verbal reported pain scores.
Study Type
Interventional
Enrollment (Actual)
44
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Winston-Salem, North Carolina, United States, 27157
- Wake Forest Baptist Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 95 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Any patient between the ages of 18 and 95 years undergoing a primary elective, unilateral DAA total hip arthroplasty.
Exclusion Criteria:
- If the patient uses more than 40mg of Oxycodone equivalents per 24 hours or is on extended release opioid formulations.
- Indication for surgery is secondary to trauma and/or hip fracture
- If there is a contraindication to the performance of a regional block
- Concomitant anticoagulation use or documented coagulopathy
- Infectious or dermatologic conditions in the area of block placement that would otherwise increase the risk of peripheral nerve blockade
- Presence of progressive neurologic deficit effecting peripheral nerves
- Allergy or adverse reaction to study drugs to include: fentanyl, epinephrine, and amide local anesthetics
- American Society of Anesthesia Physical Classification score > or = to 4
- Allergies to study drugs other than local anesthetic
- BMI > 40
- Patient refusal
- Pregnancy
- Institutionalized individuals
- Extremes of age: Age > 95 or < 18
- Non English speaking or inability to reliably participate in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: LPB Unilateral DAA THA
Patients will be randomized to receive either a LPB or QLB for post-operative analgesia.
Randomization to either LPB or QLB will occur via block randomization using sealed sequentially numbered opaque envelopes that will correspond to the order with which patients are enrolled.
Patients and research assistants will be blinded to their randomization by administration of intravenous sedation (titrated to patient comfort), utilization of ultrasonography to visualize pertinent structures for both blocks, and by the nature of the block technique themselves both being in close proximity on the posterior lower back.
|
The LPB will be performed in a lateral position, but modified to utilize ultrasound guidance to enhance our ability to quickly and safely locate the lumbar plexus as well as to avoid unblinding with regard to the traditional landmark LPB technique.
For both LPB and QLB a TOTAL DOSE of 20 cc of the following local anesthetic mixture will be administered: Ropivacaine 0.2% and Epinephrine - 2.5 mcg/cc (1:400,000 concentration).
Other Names:
|
|
Experimental: QLB Unilateral DAA THA
Patients will be randomized to receive either a LPB or QLB for post-operative analgesia.
Randomization to either LPB or QLB will occur via block randomization using sealed sequentially numbered opaque envelopes that will correspond to the order with which patients are enrolled.
Patients and research assistants will be blinded to their randomization by administration of intravenous sedation (titrated to patient comfort), utilization of ultrasonography to visualize pertinent structures for both blocks, and by the nature of the block technique themselves both being in close proximity on the posterior lower back.
|
The QLB will be performed in a lateral position in a manner consistent with the technique first described by Børglum.
For both LPB and QLB a TOTAL DOSE of 20 cc of the following local anesthetic mixture will be administered: Ropivacaine 0.2% and Epinephrine - 2.5 mcg/cc (1:400,000 concentration).
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Verbal numeric pain score with hip flexion at 6hrs (Numeric Rating Scale (NRS))
Time Frame: 6 hours post block
|
Quantified on an 10 point pain scale with 0 representing "no pain" and 10 representing "worst pain imaginable".
Higher scores denotes worse outcomes.
|
6 hours post block
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time to first analgesic
Time Frame: During hospitalization, up to 24hrs
|
Time from PACU discharge to first requested analgesic
|
During hospitalization, up to 24hrs
|
|
Total opioid consumption over 24 hours
Time Frame: 24 hrs post block
|
Total opioid consumption in the first 24hrs
|
24 hrs post block
|
|
Verbal numeric pain score at 6hrs at rest (NRS)
Time Frame: 6hrs post block
|
Quantified on an 10 point pain scale with 0 representing "no pain" and 10 representing "worst pain imaginable".
Higher scores denotes worse outcomes.
|
6hrs post block
|
|
Verbal numeric pain score at rest and with movement at 24hrs post block
Time Frame: 24hrs post block
|
Quantified on an 10 point pain scale with 0 representing "no pain" and 10 representing "worst pain imaginable".
Higher scores denotes worse outcomes.
|
24hrs post block
|
|
Ability to straight leg raise on POD1
Time Frame: Post operative day 1
|
Is the patient able to perform an unassisted straight leg raise
|
Post operative day 1
|
|
Rates of opioid related side effects (nausea, vomiting, pruritis)
Time Frame: Within 24hrs post block
|
Has the patient had any nausea, vomiting, or pruritis within the first 24hrs
|
Within 24hrs post block
|
|
Patient satisfaction utilizing a Likert-scale questionnaire
Time Frame: Post operative day 1
|
A patient satisfaction survey to administered on post operative day 1
|
Post operative day 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Christopher J Edwards, MD, Wake Forest University Health Sciences
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 4, 2019
Primary Completion (Actual)
November 22, 2019
Study Completion (Actual)
November 22, 2019
Study Registration Dates
First Submitted
January 18, 2018
First Submitted That Met QC Criteria
January 18, 2018
First Posted (Actual)
January 24, 2018
Study Record Updates
Last Update Posted (Actual)
May 12, 2020
Last Update Submitted That Met QC Criteria
May 8, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00048845
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis
-
Hacettepe UniversityNot yet recruitingThumb Osteoarthritis | Trapeziometacarpal Osteoarthritis | Carpometacarpal Osteoarthritis | Thumb Basal Joint OsteoarthritisTurkey (Türkiye)
-
Sanford HealthTerminatedKnee Osteoarthritis | Hip Osteoarthritis | Shoulder Osteoarthritis | Ankle Osteoarthritis | Wrist OsteoarthritisUnited States
-
Edin MešanovićCompletedOsteoarthritis | Osteoarthritis of the Knee | Osteoarthritis of Knee | Osteoarthritis of the Knees | Osteoarthritis (OA) of the Knee | Osteoarthritis Knee | Osteoarthritis in the Knee | Osteoarthritis of Knee JointBosnia and Herzegovina
-
Hospital for Special Surgery, New YorkRoyal Infirmary of EdinburghRecruitingKnee Osteoarthritis | Hip Osteoarthritis | Shoulder OsteoarthritisUnited States, United Kingdom
-
Middlesex UniversityRecruitingOsteoarthritis | Osteoarthritis (OA) | Osteoarthritis (OA) of the Knee | Osteoarthritis (OA) of the HipUnited Kingdom
-
Golden Jubilee National HospitalJohnson & Johnson; DePuy OrthopaedicsNot yet recruitingOsteoarthritis | Knee Osteoarthritis | Osteoarthritis (OA) | Osteo Arthritis | Osteoarthritis in the Knee | Osteoarthritis (Knee) | Osteo Arthritis of the KneeUnited Kingdom
-
University of EdinburghHospital for Special Surgery, New YorkActive, not recruitingKnee Osteoarthritis | Hip Osteoarthritis | Shoulder OsteoarthritisUnited Kingdom
-
Medical University of WarsawUnknownOsteoarthritis | Knee Osteoarthritis | Hip Osteoarthritis | Glenohumeral OsteoarthritisPoland
-
Medical University of WarsawUnknownOsteoarthritis | Knee Osteoarthritis | Hip Osteoarthritis | Glenohumeral OsteoarthritisPoland
-
Istanbul University - CerrahpasaCompletedKnee Osteoarthritis | Knee Osteoarthritis (Knee OA)Turkey (Türkiye)
Clinical Trials on LPB
-
University Hospital Inselspital, BerneTerminatedPain, Postoperative | Pediatric Anesthesia | Regional AnesthesiaSwitzerland
-
Wake Forest University Health SciencesCompleted
-
Shanghai 6th People's HospitalCompletedAnesthesia, Local | Hip Fractures | Hip Osteoarthritis | Osteonecrosis of Femoral HeadChina
-
Udayana UniversityCompletedLower Extremity SurgeryIndonesia